Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

JP Morgan Maintains Overweight on Synovus Finl, Lowers Price Target to $46

By Benzinga Newsdesk
July 1, 9:36 AM
JP Morgan analyst Steven Alexopoulos maintains Synovus Finl (NYSE:SNV) with a Overweight and lowers the price target from $60 to $46.

SNV

Read More
1 minute read
  • Contracts
  • News
  • Small Cap

Embraer Collaborates With Toyota To Maximize Production System Efficiency

By Akanksha Bakshi
July 1, 9:34 AM
Embraer SA (NYSE:ERJ) has signed an agreement with Toyota Motors Corp (NYSE:TM) Toyota do Brasil to embrace Toyota Production System (TPS) principles and…

ERJ

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

JP Morgan Maintains Overweight on Silvergate Capital, Lowers Price Target to $90

By Benzinga Newsdesk
July 1, 9:33 AM
JP Morgan analyst Steven Alexopoulos maintains Silvergate Capital (NYSE:SI) with a Overweight and lowers the price target from $200 to $90.

SI

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About Fidelity National Info?

By Benzinga Insights
July 1, 9:30 AM
Fidelity National Info's (NYSE:FIS) short percent of float has risen 76.64% since its last report. The company recently reported that it has 6.05 million shares sold short, which is 1.89% of all regular shares that are available for trading.

FIS

Read More
1 minute read
  • Analyst Ratings

Analyst Ratings for Wingstop

By Benzinga Insights
July 1, 9:30 AM
Analysts have provided the following ratings for Wingstop (NASDAQ:WING) within the last quarter:

WING

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About Freeport-McMoRan?

By Benzinga Insights
July 1, 9:30 AM
Freeport-McMoRan's (NYSE:FCX) short percent of float has risen 15.38% since its last report. The company recently reported that it has 25.87 million shares sold short, which is 1.8% of all regular shares that are available for trading.

FCX

Read More
1 minute read
  • Analyst Ratings

Where Sun Communities Stands With Analysts

By Benzinga Insights
July 1, 9:30 AM
Sun Communities (NYSE:SUI) has observed the following analyst ratings within the last quarter:

SUI

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for Live Oak Bancshares

By Benzinga Insights
July 1, 9:30 AM
Analysts have provided the following ratings for Live Oak Bancshares (NASDAQ:LOB) within the last quarter:

LOB

Read More
2 minute read
  • Analyst Ratings

11 Analysts Have This to Say About State Street

By Benzinga Insights
July 1, 9:30 AM
Analysts have provided the following ratings for State Street (NYSE:STT) within the last quarter:

STT

Read More
1 minute read
  • Analyst Ratings

7 Analysts Have This to Say About Iovance Biotherapeutics

By Benzinga Insights
July 1, 9:30 AM
Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter:

IOVA

Posts pagination

Previous 1 … 19,057 19,058 19,059 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service